TIE2-positive cells in the nucleus pulposus with a purpose: the who, what and why.

IF 14.5 2区 医学 Q1 CELL BIOLOGY
Jordy Schol, Luca Ambrosio, Clara Ruiz-Fernandez, Leon Schlagenhof, Chantal Voskamp, Lisanne T Laagland, Erika Matsushita, Hazuki Soma, Takayuki Warita, Gianluca Vadalà, Marianna A Tryfonidou, Benjamin Gantenbein, Daisuke Sakai
{"title":"TIE2-positive cells in the nucleus pulposus with a purpose: the who, what and why.","authors":"Jordy Schol, Luca Ambrosio, Clara Ruiz-Fernandez, Leon Schlagenhof, Chantal Voskamp, Lisanne T Laagland, Erika Matsushita, Hazuki Soma, Takayuki Warita, Gianluca Vadalà, Marianna A Tryfonidou, Benjamin Gantenbein, Daisuke Sakai","doi":"10.1186/s12929-026-01220-7","DOIUrl":null,"url":null,"abstract":"<p><p>Once thought to be solely involved in vasculogenesis, tyrosine kinase with immunoglobulin-like and EGF-like domains 2 (TIE2) has emerged as a crucial marker of progenitor-like cells in the avascular nucleus pulposus (NP), a tissue with notoriously limited regenerative capacity. Recent evidence suggests that TIE2 + NP cells play a pivotal role in disc tissue homeostasis, influencing extracellular matrix maintenance, cellular renewal, and tissue integrity. However, despite the reported regenerative potential of TIE2 + NP cells, their precise function remains enigmatic. This review consolidates in vivo, in vitro, and transcriptomic studies to validate the presence of TIE2 in the NP as a progenitor cell marker. We unravel the complexity of TIE2 + NP cells across species, highlighting key regulatory mechanisms and interspecies variations (including mice, rats, dogs, cows, sheep, pigs, and humans) that may influence their relevance as clinical- and regenerative therapeutic targets. Yet, methodological inconsistencies across studies continue to obscure our understanding of the precise role of TIE2 in NP cell biology. At present, clinical care is limited to managing pain conservatively or resorting to spinal surgery in severe cases. Thus, there exists an urgent need for innovative regenerative strategies to combat disc degeneration and its associated pain and disability. A range of emerging approaches, including biomaterials, gene therapy, and cell-based therapeutics, are under investigation. Within this context, TIE2 + NP cells are of particular interest as potential therapeutic vectors: as for example candidate cells for transplantation, as populations to be stimulated by biologic interventions, or as building blocks in tissue engineering strategies. As progenitor-like cells, they hold the theoretical potential to provide a sustained source of functional NP cells for disc maintenance and repair. By identifying existing knowledge gaps and proposing future research directions, this review aims to clarify their role and accelerate progress toward unlocking their full therapeutic potential.</p>","PeriodicalId":15365,"journal":{"name":"Journal of Biomedical Science","volume":"33 1","pages":""},"PeriodicalIF":14.5000,"publicationDate":"2026-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12952123/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Biomedical Science","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12929-026-01220-7","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Once thought to be solely involved in vasculogenesis, tyrosine kinase with immunoglobulin-like and EGF-like domains 2 (TIE2) has emerged as a crucial marker of progenitor-like cells in the avascular nucleus pulposus (NP), a tissue with notoriously limited regenerative capacity. Recent evidence suggests that TIE2 + NP cells play a pivotal role in disc tissue homeostasis, influencing extracellular matrix maintenance, cellular renewal, and tissue integrity. However, despite the reported regenerative potential of TIE2 + NP cells, their precise function remains enigmatic. This review consolidates in vivo, in vitro, and transcriptomic studies to validate the presence of TIE2 in the NP as a progenitor cell marker. We unravel the complexity of TIE2 + NP cells across species, highlighting key regulatory mechanisms and interspecies variations (including mice, rats, dogs, cows, sheep, pigs, and humans) that may influence their relevance as clinical- and regenerative therapeutic targets. Yet, methodological inconsistencies across studies continue to obscure our understanding of the precise role of TIE2 in NP cell biology. At present, clinical care is limited to managing pain conservatively or resorting to spinal surgery in severe cases. Thus, there exists an urgent need for innovative regenerative strategies to combat disc degeneration and its associated pain and disability. A range of emerging approaches, including biomaterials, gene therapy, and cell-based therapeutics, are under investigation. Within this context, TIE2 + NP cells are of particular interest as potential therapeutic vectors: as for example candidate cells for transplantation, as populations to be stimulated by biologic interventions, or as building blocks in tissue engineering strategies. As progenitor-like cells, they hold the theoretical potential to provide a sustained source of functional NP cells for disc maintenance and repair. By identifying existing knowledge gaps and proposing future research directions, this review aims to clarify their role and accelerate progress toward unlocking their full therapeutic potential.

髓核中的tie2阳性细胞有一个目的:谁,什么和为什么。
酪氨酸激酶具有免疫球蛋白样结构域和表皮生长因子样结构域2 (TIE2),曾被认为仅参与血管发生,现已成为无血管髓核(NP)中祖细胞样细胞的重要标志,NP是一种众所周知的再生能力有限的组织。最近的证据表明,TIE2 + NP细胞在椎间盘组织稳态中起关键作用,影响细胞外基质维持、细胞更新和组织完整性。然而,尽管报道了TIE2 + NP细胞的再生潜力,但它们的确切功能仍然是谜。这篇综述整合了体内、体外和转录组学研究,以验证TIE2在NP中作为祖细胞标记物的存在。我们揭示了TIE2 + NP细胞跨物种的复杂性,强调了关键的调控机制和种间变异(包括小鼠、大鼠、狗、牛、羊、猪和人类),这些可能会影响它们作为临床和再生治疗靶点的相关性。然而,研究方法的不一致性继续模糊我们对TIE2在NP细胞生物学中的确切作用的理解。目前,临床护理仅限于保守治疗疼痛或在严重病例中采取脊柱手术。因此,迫切需要创新的再生策略来对抗椎间盘退变及其相关的疼痛和残疾。包括生物材料、基因疗法和细胞疗法在内的一系列新兴疗法正在研究中。在这种背景下,TIE2 + NP细胞作为潜在的治疗载体尤其令人感兴趣:例如,作为移植的候选细胞,作为生物干预刺激的群体,或作为组织工程策略的构建块。作为祖细胞样细胞,它们理论上有可能为椎间盘维持和修复提供持续的功能性NP细胞来源。通过确定现有的知识差距和提出未来的研究方向,本综述旨在阐明它们的作用并加速释放其全部治疗潜力的进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Biomedical Science
Journal of Biomedical Science 医学-医学:研究与实验
CiteScore
18.50
自引率
0.90%
发文量
95
审稿时长
1 months
期刊介绍: The Journal of Biomedical Science is an open access, peer-reviewed journal that focuses on fundamental and molecular aspects of basic medical sciences. It emphasizes molecular studies of biomedical problems and mechanisms. The National Science and Technology Council (NSTC), Taiwan supports the journal and covers the publication costs for accepted articles. The journal aims to provide an international platform for interdisciplinary discussions and contribute to the advancement of medicine. It benefits both readers and authors by accelerating the dissemination of research information and providing maximum access to scholarly communication. All articles published in the Journal of Biomedical Science are included in various databases such as Biological Abstracts, BIOSIS, CABI, CAS, Citebase, Current contents, DOAJ, Embase, EmBiology, and Global Health, among others.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书